Berkshire Hills Bancorp, Inc. (BHLB)

Akoya Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Interest Income on Loans	550.21	556.53	512.54	335.31	282.16	358.02
Interest Income on Investments	57.41	57.41	63.76	51.95	46.9	51.77
Total Interest Income	607.62	613.94	576.3	387.26	329.07	409.78
Interest Paid on Deposits	216.68	228.02	158.91	33.44	27.24	72.72
Interest Paid on Borrowings	34.34	34.34	48.34	9.22	10.66	20.29
Total Interest Expense	251.02	262.35	207.25	42.66	37.9	93
Net Interest Income	356.61	351.59	369.05	344.6	291.17	316.78
Net Interest Income Growth (YoY)	0.33%	-4.73%	7.09%	18.35%	-8.09%	-13.27%
Trust Income	10.96	10.84	10.2	10.01	10.53	9.29
Mortgage Banking Activities	-	-	-	-	-	5.19
Gain (Loss) on Sale of Assets	16.24	16.24	-	-	52.94	1.24
Gain (Loss) on Sale of Investments	0.13	-49.93	-32.56	-5.54	-4.23	-11.17
Other Non-Interest Income	29.72	24.86	20.66	19.95	33.51	33.85
Total Non-Interest Income	103.3	48.41	42.78	68.94	143.25	66.31
Non-Interest Income Growth (YoY)	-	13.16%	-37.94%	-51.88%	116.04%	-21.07%
Revenues Before Loan Losses	459.91	400	411.83	413.53	434.41	383.09
Provision for Loan Losses	21	24	32	11	-0.5	75.88
Revenue	438.91	376	379.83	402.53	434.91	307.21
Revenue Growth (YoY)	35.24%	-1.01%	-5.64%	-7.45%	41.57%	-25.77%
Salaries and Employee Benefits	151.21	152.14	151.78	145.4	146.42	143.11
Occupancy Expenses	20.68	22.57	26.62	27.94	30.88	31.06
Federal Deposit Insurance	-0.42	-	-	-	3.76	5.88
Amortization of Goodwill & Intangibles	4.51	4.6	4.82	5.13	5.2	6.18
Selling, General & Administrative	77.92	79.84	82.52	72.88	67.48	65
Other Non-Interest Expense	23.94	27.85	29.51	28.46	26.35	29.28
Total Non-Interest Expense	277.84	286.99	295.25	279.81	280.11	280.64
EBT Excluding Unusual Items	161.07	89.01	84.58	122.73	154.8	26.57
Pretax Income	150.87	79.52	78.32	113.82	149.02	-533.03
Income Tax Expense	37.61	18.51	8.72	21.29	30.36	-19.85
Earnings From Continuing Operations	113.25	61	69.6	92.53	118.66	-513.18
Earnings From Discontinued Operations	-	-	-	-	-	-19.84
Net Income	113.25	61	69.6	92.53	118.66	-533.02
Net Income to Common	113.25	61	69.6	92.53	118.66	-533.02
Net Income Growth	416.26%	-12.35%	-24.79%	-22.02%	-	-
Basic Shares Outstanding	44	43	43	46	49	50
Diluted Shares Outstanding	44	43	44	46	50	50
Shares Change (YoY)	3.27%	-1.71%	-5.25%	-7.35%	-1.42%	1.72%
EPS (Basic)	2.57	1.44	1.61	2.03	2.41	-10.60
EPS (Diluted)	2.56	1.43	1.60	2.02	2.39	-10.60
EPS Growth	404.16%	-10.63%	-20.79%	-15.48%	-	-
Dividend Per Share	0.720	0.720	0.720	0.540	0.480	0.720
Dividend Growth	-	-	33.33%	12.50%	-33.33%	-21.74%
Effective Tax Rate	24.93%	23.28%	11.14%	18.70%	20.37%	-

Updated Jul 24, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.

SEC Filings: 10-K · 10-Q